Sientra lowers guidance, shares drop 20%
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sientra wins new FDA approval
The U.S. Food and Drug Administration approved a new breast implant on July 6 made by Goleta-based Sientra. Sientra’s Low Plus Profile Projection Breast Implant will be commercially available to plastic surgeons in the United States in late July, the company said in a news release. It is for cosmetic surgery for women at least Read More →
Sientra reports growing revenue, shrinking losses in Q1
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sientra reports rising revenue, declining losses
Goleta-based Sientra reported record revenue for the fourth quarter and full year of 2021, and while the company still saw net losses, they were lower, the company reported March 23. Sientra, a breast implant manufacturer, had revenue of $22.6 million for the quarter, representing growth of 26.6% year-over-year, excluding discontinued operations. For the full year, Read More →
Sientra shares up after company releases 2021 revenue estimates
The Goleta-based breast implant manufacturer Sientra expects growth in the fourth quarter of 2021 and estimates its “highest-ever breast products yearly revenue” of up to $81 million for the full year, the company said Jan. 10. Sientra reported that its preliminary unaudited revenue from operations for the fourth quarter of 2021 is expected to be Read More →
Sientra misses earnings expectations but shares still gain after Q3 report
Goleta-based Sientra missed analysts’ expectations when it released financial results for the third quarter of 2021 on Nov. 10, posting a net loss when accounting for certain one-time factors such as the relief of its paycheck protection program loan. Sientra, a plastic surgery device company specializing in breast implants, had net income of $28.4 million Read More →
Sientra reports smaller loss for Q2
Sientra recorded a net loss in its most recent quarter, missing investor expectations, even as the company’s financials improved, according to financial results released Aug. 10. The Goleta-based breast implant manufacturer reported an $18.5 million loss from continuing operations in the second quarter, or 32 cents per share. The loss was a 40.7% decrease from Read More →
